Search Results - Hecquet, Carole

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Once-Daily Lixisenatide in Combination with Basal Insulin ± Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes Selectively Reduces Postprandial Hyperglycemic Daytime Exposure

    Once-Daily Lixisenatide in Combination with Basal Insulin ± Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes Selectively Reduces Postprandial Hyperglycemic Daytime Ex... by Bajaj, Harpreet S, Gomez-Huelgas, Ricardo, Riddle, Matthew C, Seino, Yutaka, Cariou, Bertrand, Roy-Duval, Christine, Hecquet, Carole A, Digenio, Andres, Rosenstock, Julio

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Adaptive and repeated cumulative meta-analyses of safety data during a new drug development process

    Adaptive and repeated cumulative meta-analyses of safety data during a new drug development process by Quan, Hui, Ma, Yingqiu, Zheng, Yan, Cho, Meehyung, Lorenzato, Christelle, Hecquet, Carole

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    145 - Plasma C-Peptide Concentration and Risk of Hypoglycemia in People with T2DM treated with Insulin Glagine 300 U/mL (Gla-300) or Insulin Glargine 100 U/mL (Gla-100)

    145 - Plasma C-Peptide Concentration and Risk of Hypoglycemia in People with T2DM treated with Insulin Glagine 300 U/mL (Gla-300) or Insulin Glargine 100 U/mL (Gla-100) by Bolli, Geremia, Ritzel, Robert, Yale, Jean-François, Escalada, Javier, Davies, Melanie, Landgraf, Wolfgang, Bertolini, Monica, Hecquet, Carole, Yki-Järvinen, Hannele, Rosenstock, Julio

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Plasma C-Peptide Concentration and Risk of Hypoglycemia in People with T2DM treated with Insulin Glagine 300 U/mL (Gla-300) or Insulin Glargine 100 U/mL (Gla-100)

    Plasma C-Peptide Concentration and Risk of Hypoglycemia in People with T2DM treated with Insulin Glagine 300 U/mL (Gla-300) or Insulin Glargine 100 U/mL (Gla-100) by Bolli, Geremia, Ritzel, Robert, Yale, Jean-François, Escalada, Javier, Davies, Melanie, Landgraf, Wolfgang, Bertolini, Monica, Hecquet, Carole, Yki-Järvinen, Hannele, Rosenstock, Julio

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial

    The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial... by Cohen, Marc, Gensini, Gian Franco, Maritz, Frans, Gurfinkel, Enrique P, Huber, Kurt, Timerman, Ari, Krzeminska-Pakula, Maria, Danchin, Nicolas, White, Harvey D, Santopinto, Jose, Bigonzi, Frederique, Hecquet, Carole, Vittori, Luc

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial

    Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETA... by Cohen, Marc, Gensini, Gian Franco, Maritz, Frans, Gurfinkel, Enrique P, Huber, Kurt, Timerman, Ari, Krzeminska-Pakula, Maria, Santopinto, Jose, Hecquet, Carole, Vittori, Luc

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Prospective evaluation of clinical outcomes after acute st-elevation myocardial Infarction in patients who are ineligible for reperfusion therapy: Preliminary results from the TETAMI registry and randomized trial: Update 2003: Clinical Trials in Acute Coronary Syndromes

    Prospective evaluation of clinical outcomes after acute st-elevation myocardial Infarction in patients who are ineligible for reperfusion therapy: Preliminary results from the TETA... by COHEN, Marc, GENSINI, Gian Franco, MARITZ, Frans, GURFINKEL, Enrique P, HUBER, Kurt, TIMERMAN, Ari, KRZEMINSKA-PAKULA, Maria, SANTOPINTO, Jose, HECQUET, Carole, VITTORI, Luc

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI)

    The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial... by Cohen, Marc, Gensini, Gian Franco, Maritz, Frans, Gurfinkel, Enrique P, Huber, Kurt, Timerman, Ari, Krzeminska-Pakula, Maria, Danchin, Nicolas, White, Harvey D, Santopinto, Jose, Bigonzi, Frederique, Hecquet, Carole, Vittori, Luc

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    The Safety and Efficacy of Subcutaneous Enoxaparin Versus intravenous unfractionated Heparin and Tirofiban Versus Placebo in the Treatment of Acute ST-segment Elevation Myocardial Infarction Patients Ineligible for Reperfusion (TETAMI) A randomized trial. Commentary

    The Safety and Efficacy of Subcutaneous Enoxaparin Versus intravenous unfractionated Heparin and Tirofiban Versus Placebo in the Treatment of Acute ST-segment Elevation Myocardial... by COHEN, Marc, GENSINI, Gian Franco, BIGONZI, Frederique, HECQUET, Carole, VITTORI, Luc, HERRMANN, Howard C, MARITZ, Frans, GURFINKEL, Enrique P, HUBER, Kurt, TIMERMAN, Ari, KRZEMINSKA-PAKULA, Maria, DANCHIN, Nicolas, WHITE, Harvey D, SANTOPINTO, Jose

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: